Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?

In spite of its widespread use, benznidazole's (BNZ) toxicity and low efficacy remains as major drawbacks that impair successful treatments against Chagas disease. Previously, attempting to increase the selectivity and reduce its toxicity on infected tissues, multilamellar liposomes (MLV) compo...

Full description

Bibliographic Details
Main Authors: Maria Jose Morilla, Maria Jimena Prieto, Eder Lilia Romero
Format: Article
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2005-04-01
Series:Memórias do Instituto Oswaldo Cruz.
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000200017